Charles River Laboratories, a Wilmington, Mass., pharma services giant, is closing a Skokie office that will result in the ...

Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

Charles River Trader, part of the Charles River Investment Management System, offers full order and execution management (OEMS) in a single system. Charles River Trader supports multi-currency trading ...

TD Cowen raised the firm’s price target on Charles River (CRL) to $227 from $203 and keeps a Hold rating on the shares. The firm said solid 3Q results are positive indication thhe company is nearing a ...

A charter company working for Charles River Laboratories, one of the largest U.S. clinical research organizations, was recently fined by Canadian authorities for improperly shipping long-tailed ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

Races begin this Friday on the Charles River at 7:45 a.m. and run until just before 11 a.m. The regatta continues Saturday and Sunday, with races from 7:45 a.m. until 4 p.m. Click here for the ...

Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share ...

With a market cap of $9.4 billion, Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) is a leading contract research organization (CRO) in the healthcare sector.

UBS raised the firm’s price target on Charles River (CRL) to $250 from $240 and keeps a Buy rating on the shares post the earnings ...